L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats #
Authors:
- Vanessa StadlbauerVanessa Stadlbauer
- Ceri D. DaviesCDCeri D. Davies
- Rajiv JalanRJRajiv Jalan
Open Access
- 23 June 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 50 (1) , 155-164
Abstract
Treatment of hyperammonemia and hepatic encephalopathy in cirrhosis is an unmet clinical need. The aims of this study were to determine whether L-ornithine and phenylacetate/phenylbutyrate (administered as the pro-drug phenylbutyrate) (OP) combined are synergistic and produce sustained reduction in ammonia by L-ornithine acting as a substrate for glutamine synthesis, thereby detoxifying ammonia, and the phenylacetate excreting the ornithine-derived glutamine as phenylacetylglutamine in the urine. Sprague-Dawley rats were studied 4 weeks after bile duct ligation (BDL) or sham operation. Study 1: Three hours before termination, an internal carotid sampling catheter was inserted, and intraperitoneal saline (placebo), OP, phenylbutyrate, or L-ornithine were administered after randomization. BDL was associated with significantly higher arterial ammonia and brain water and lower brain myoinositol (P < 0.01, respectively), compared with sham-operated controls, which was significantly improved in the OP-treated animals; arterial ammonia (P < 0.001), brain water (P < 0.05), brain myoinositol (P < 0.001), and urinary phenylacetylglutamine (P < 0.01). Individually, L-ornithine or phenylbutyrate were similar to the BDL group. In study 2, BDL rats were randomized to saline or OP administered intraperitoneally for 6 hours or 3, 5, or 10 days and were sacrificed between 4.5 and 5 weeks. The results showed that the administration of OP was associated with sustained reduction in arterial ammonia (P < 0.01) and brain water (P < 0.01) and markedly increased arterial glutamine (P < 0.01) and urinary excretion of phenylacetylglutamine (P < 0.01) in each of the OP treated groups. Conclusion: The results of this study provide proof of the concept that L-ornithine and phenylbutyrate/phenylacetate act synergistically to produce sustained improvement in arterial ammonia, its brain metabolism, and brain water in cirrhotic rats. (Hepatology 2009.)Keywords
This publication has 35 references indexed in Scilit:
- Endotoxemia produces coma and brain swelling in bile duct ligated ratsHepatology, 2007
- l-Ornithine phenylacetate (OP): A novel treatment for hyperammonemia and hepatic encephalopathyMedical Hypotheses, 2007
- Systemic and regional haemodynamics in pigs with acute liver failure and the effect of albumin dialysisScandinavian Journal of Gastroenterology, 2006
- Ammonia toxicity under hyponatremic conditions in astrocytes: De novo synthesis of amino acids for the osmoregulatory responseNeurochemistry International, 2005
- Induced Hyperammonemia Alters Neuropsychology, Brain Mr Spectroscopy and Magnetization Transfer in CirrhosisHepatology, 2003
- Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic ratHepatology, 1999
- Effects of ornithine aspartate on plasma ammonia and plasma amino acids in patients with cirrhosis. A double-blind, randomized study using a four-fold crossover designJournal of Hepatology, 1993
- The treatment of inborn errors of the urea cycleNature, 1981
- Ammonia production by the small intestine of the ratBiochimica et Biophysica Acta (BBA) - General Subjects, 1976
- A BIOCHEMICAL STUDY OF CEREBRAL TISSUE, AND OF THE CHANGES IN CEREBRAL ÆDEMABrain, 1939